Concepedia

C S Johnson

CS

Statistics

Publications

8

Citations

385

H-Index

8

Active since

1988

Affiliations

University of Pittsburgh(Current)

Cancer Research Center

C S Johnson is an author at University of Pittsburgh specializing in oncology, medicine, and tumor immunology.

Publications per year

1988–1999

8

Publications

8

A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.

David C. Smith, C S Johnson, C C Freeman et al. · PubMed · 1999 · 174 citations

, , +17

Antitumor effects of recombinant human interleukin 1 alpha in RIF-1 and Panc02 solid tumors.

Paul G. Braunschweiger, C S Johnson, Nirmal Kumar et al. · PubMed · 1988 · 59 citations

, , +13

Integrin activation suppresses etoposide-induced DNA strand breakage in cultured murine tumor-derived endothelial cells.

Dale G. Hoyt, James M. Rusnak, Robert Mannix et al. · PubMed · 1996 · 50 citations

, , +17

31P-nuclear magnetic resonance studies of the effect of recombinant human interleukin 1 alpha on the bioenergetics of RIF-1 tumors.

Ioannis Constantinidis, Paul G. Braunschweiger, Janna P. Wehrle et al. · PubMed · 1989 · 31 citations

, , +13

Negative regulators of in vivo erythropoiesis: interaction of IL-1 alpha and TNF-alpha and the lack of a strict requirement for T or NK cells for their activity.

C S Johnson, S C Pourbohloul, Philip Furmanski · PubMed · 1991 · 28 citations

, , +12

1–5 of 8